We examined the expression and ligand specificity of the α2β1 integrin on human mammary epithelial cells (HMEC) and a panel of breast carcinoma cell lines in vitro. We found that the α2β1 integrin was universally, but quite variably expressed on these cells by FACS analysis. No significant correlation was observed between its expression and other known cellular phenotypes. Substrate attachment assays using blocking antibodies demonstrated that α2β1 integrin served as a receptor for collagen on HMEC and almost all breast carcinoma cells. However, its contribution to laminin binding of these cells appeared to be related to cellular differentiation as evaluated by sex steroid receptor status and by markers of epithelial-mesenchymal transition, i.e. loss of E-cadherin and expression of vimentin. Two different populations of non-malignant immortalized HMEC (184A1N4 and MCF-10A) contained cells capable of using α2β1 integrin as a laminin receptor. Breast cancer cell lines positive for estrogen receptor (ER) and E-cadherin (MCF-7, T47D, ZR75-1) could also use α2β1 integrin as a laminin receptor. Conversely, α2β1 integrin appeared to be incapable of binding to laminin or to be a very minor receptor for laminin on metastatic ER-negative breast carcinoma cells that expressed vimentin (MDA-MB 231, MDA-MB 435, and MDA-MB 436). These findings suggest that the ligand specificity of α2β1 integrin, i.e. its function as a laminin receptor, may be regulated during the malignant progression of breast carcinoma cells. A reduced contribution of α2β1 integrin to the cellular laminin binding appears to be associated with an increased malignant phenotype and with an epithelial-mesenchymal transition of breast carcinoma cells.
Similar content being viewed by others
References
Albelda, SM and Buck, CA, 1990, Integrins and other cell adhesion molecules. FASEB J, 4, 2868–80.
Ruoslahti, E, 1991, Integrins. J Clin Invest, 87, 1–5.
Hynes, RO, 1992, Integrins: Versatility, modulation, and signaling in cell adhesion. Cell, 69, 11–25.
Hynes, RO, 1987, Integrins: A family of cell surface receptor. Cell, 48, 549–54.
Blood, CH and Zetter, BR, 1990, Tumor interactions with the vasculature: angiogenesis and tumor metastasis. Biochim Biophys Acta, 1032, 89–118.
Liotta, LA, Steeg, PS and Stetler-Stevenson, WG, 1991, Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell, 64, 327–36.
Auerbach, R, 1988, Patterns of tumor metastasis: organ selectivity in the spread of cancer cells. Lab Invest, 58, 361–4.
Maemura, M and Dickson, RB, 1994, Are cellular adhesion molecules involved in the metastasis of breast cancer? Breast Cancer Res Treat, 32, 239–60.
Albelda, SM, 1993, Role of integrins and other cell adhesion molecules in tumor progression and metastasis. Lab Invest, 68, 4–17.
Pignatelli, M, Smith, MEF and Bodmer, WF, 1990, Low expression of collagen receptors in moderate and poorly differentiated colorectal adenocarcinomas. Br J Cancer, 61, 636–8.
Hall, PA, Coates, P, Lemoine, NR and Horton, MA, 1991, Characterization of integrin chains in normal and neoplastic human pancreas. J Pathol, 165, 33–41.
Korhonen, M, Laitinen, L, Ylänne, J et al., 1992, Integrin distribution in renal cell carcinomas of various grades of malignancy. Am J Pathol, 141, 1161–71.
Suzuki, S, Takahashi, T, Nakamura, S et al., 1993, Alteration of integrin expression in human lung cancer. Jpn J Cancer Res, 84, 168–74.
Jones, JL, Critchley, DR and Walker, RA, 1992, Alteration of stromal protein and integrin expression in breast — a marker of premalignant change? J Pathol, 167, 399–406.
Plantefaber, LC and Hynes, RO, 1989, Changes in integrin receptors on oncogenically transformed cells. Cell, 56, 281–90.
Lin, C-S, Zhang, K and Kramer, R, 1993, α6 integrin is up-regulated in step increments accompanying neoplastic transformation and tumorigenic conversion of human fibroblasts. Cancer Res, 53, 2950–3.
Akiyama, SK, Larjava, H and Yamada, KM, 1990, Differences in the biosynthesis and localization of the fibronectin receptor in normal and transformed cultured human cells. Cancer Res, 50, 1601–7.
Dedhar, S and Saulnier, R, 1990, Alterations in integrin receptor expression on chemically transformed human cells: specific enhancement of laminin and collagen receptor complexes. J Cell Biol, 110, 481–9.
Danen, EHJ, van Muijen, GNP, van de Wiel-van Kemenade, E et al., 1993, Regulation of integrin-mediated adhesion to laminin and collagen in human melanocytes and in non-metastatic and highly metastatic human melanoma cells. Int J Cancer, 54, 315–21.
Dedhar, S, Saulnier, R, Nagle, R, and Overall, CM, 1993, Specific alterations in the expression of α3β1 and α6β4 integrins in highly invasive and metastatic variants of human prostate carcinoma cells selected by in vitro invasion through reconstituted basement membrane. Clin Exp Metastasis, 11, 391–400.
Yamada, KM, Kennedy, DW, Yamada, SS et al., 1990, Monoclonal antibody and synthetic peptide inhibitors of human tumor cell migration. Cancer Res, 50, 4485–96.
Fujita, S, Suzuki, H, Kinoshita, M and Hirohashi, S, 1992, Inhibition of cell attachment, invasion and metastasis of human carcinoma cells by anti-integrin β1, subunit antibody. Jpn J Cancer Res, 83, 1317–26.
Bonkhoff, H, Stein, U and Remberger, K, 1993, Differential expression of α6 and α2 very late antigen integrins in the normal, hyperplastic, and neoplastic prostate: simultaneous demonstration of cell surface receptors and their extracellular ligands. Hum Pathol, 24, 243–8.
Nigam, AK, Savage, FJ, Boulos, PB et al., 1993, Loss of cell-cell and cell-matrix adhesion molecules in colorectal cancer. Br J Cancer, 68, 507–14.
Chen, FA, Repasky, EA and Bankert, RB, 1991, Human lung tumor-associated antigen identified as an extracellular matrix adhesion molecule. J Exp Med, 173, 1111–19.
Zutter, MM, Mazoujian, G and Santoro, SA, 1990, Decreased expression of integrin adhesive protein receptors in adenocarcinoma of the breast. Am J Pathol, 137, 863–70.
Pignatelli, M, Cardillo, MR, Hanby, A and Stamp, GWH, 1992, Integrins and their accessory adhesion molecules in mammary carcinomas: loss of polarization in poorly differentiated tumors. Hum Pathol, 23, 1159–66.
Zutter, MM, Krigman, HR and Santro, SA, 1993, Altered expression in adenocarcinoma of the breast. Analysis by in situ hybridization. Am J Pathol, 142, 1439–48.
Arihiro, K, Inai, K, Kurihara, K et al., 1993, Loss of VLA-2 collagen receptor in breast carcinoma, facilitating invasion and metastasis. Jpn J Cancer Res, 84, 726–33.
Mechtersheimer, G, Munk, M, Barth, T, Koretz, K and Möller, P, 1993, Expression of β1 integrins in non-neoplastic mammary epithelium, fibroadenoma and carcinoma of the breast. Virchows Archiv A, 422, 203–10.
Berdichevsky, F, Gilbert, C, Shearer, M and Taylor-Papadimitriou, J, 1992, Collagen-induced rapid morphogenesis of human mammary epithelial cells: The role of the α2β1 integrin. J Cell Sci, 102, 437–46.
Zutter, MM and Santro, SA, 1990, Widespread histologic distribution of the 012131 integrin cell-surface collagen receptor. Am J Pathol, 137, 113–20.
33. Staatz, WD, Rajpara, SM, Wayner, EA, Carter, WG and Santoro, SA, 1989, The membrane glycoprotein Ia–IIa (VLA-2) complex mediates the Mg++-dependent adhesion of platelets to collagen. J Cell Biol, 108, 1917–24.
Elices, MJ and Hemler, ME, 1989, The human integrin VLA-2 is a collagen receptor on some cells and a collagen/laminin receptor on others. Proc Natl Acad Sci USA, 86, 9906–10.
Kirchhofer, D, Languino, LR, Ruoslahti, E and Pierschbacher, MD, 1990, α2β1 integrins from different cell types show different binding specificities. J Biol Chem, 265, 615–8.
Languino, LR, Gehlsen, KR, Wayner, E et al., 1989, Endothelial cells use α2β1 integrin as a laminin receptor. J Cell Biol, 109, 2455–62.
Kramer, RH and Marks, N, 1989, Identification of integrin collagen receptors on human melanoma cells. J Biol Chem, 264, 4684–8.
Lampugnani, MG, Resnati, M, Dejana, E and Marchisio, PC, 1991, The role of integrins in the maintenance of endothelial monolayer integrity. J Cell Biol, 112, 479–90.
Larjava, H, Peltonen, J, Akiyama, SK et al., 1990, Novel function for β1 integrins in keratinocyte cell-cell interactions. J Cell Biol, 110, 803–15.
Akiyama, SK, Yamada, SS, Chen, W-T and Yamada, KM, 1989, Analysis of fibronectin receptor function with monoclonal antibodies: Roles in cell adhesion, migration, matrix assembly, and cytoskeletal organization. J Cell Biol, 109, 863–75.
Pischel, KD, Hemler, ME, Huang, C, Bluestein, HG and Woods Jr., VL, 1987, Use of the monoclonal antibody 12F1 to characterize the differentiation antigen VLA-2. J Immunol, 138, 226–33.
Coller, BS, Beer, JH, Scudder, LE and Steinberg, MH, 1989, Collagen-platelet interactions: evidence for a direct interaction of collagen with platelet GPIa/IIa and an indirect interaction with platelet GPIIb/IIIa mediated by adhesive proteins. Blood, 74, 182–92.
Thompson, EW, Brünner, N, Torri, J et al., 1993, The invasive and metastatic properties of hormone-independent but hormone-responsive variants of MCF-7 human breast cancer cells. Clin Exp Metastasis, 11, 15–26.
Clark, R, Stampfer, MR, Milley, R et al., 1988, Transformation of human mammary epithelial cells by oncogenic retroviruses. Cancer Res, 48, 4689–94.
Soule, HD, Maloney, TM, Wolman, SR et al., 1990, Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res, 50, 6075–86.
Engel, LW and Young, NA, 1978, Human breast carcinoma cells in continuous culture: a review. Cancer Res, 38, 4327–39.
Thompson, EW, Paik, S, Brünner, N et al., 1992, Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines. J Cell Physiol, 150, 534–44.
Sommers, CL, Thompson, EW, Torri, JA et al., 1991, Cell adhesion molecule uvomorulin expression in human breast cancer cell lines: relationship to morphology and invasive capacities. Cell Growth Diff, 2, 365–72.
Sommers, CL, Walker-Jones, D, Heckford, SE et al., 1989, Vimentin rather than keratin expression in some hormone-independent breast cancer cell lines and in oncogene-transformed mammary epithelial cells. Cancer Res, 49, 4258–63.
Boyer, B, Tucker, GC, Vallés, AM, Franke, WW and Thiery, JP, 1989, Rearrangements of desmosomal and cytoskeletal proteins during the transition from epithelial to fibroblastoid organization in cultured rat bladder carcinoma cells. J Cell Biol, 109, 1495–509.
Raymond, WA and Leong, AS-Y, 1989, Vimentin — a prognostic parameter in breast carcinoma? J Pathol, 158, 107–14.
Raymond, WA and Leong, AS-Y, 1989, Co-expression of cytokeratin and vimentin intermediate filament proteins in benign and neoplastic breast epithelium. J Pathol, 157, 299–306.
Rao, CN, Castronovo, V, Schmitt, MC et al., 1989, Evidence for a precursor of the high-affinity metastasis-associated murine laminin receptor. Biochem, 28, 7476–86.
Timpl, R, Rohde, H, Robey, PG et al., 1979, Laminin — a glycoprotem from basement membrane. J Biol Chem, 254, 9933–7.
Malinoff, HL, McCoy Jr., JP, Varani, J and Wicha, MS, 1984, Metastatic potential of murine fibrosarcoma cells is influenced by cell surface laminin. Int J Cancer, 33, 651–5.
Terranova, VP, Williams, JE, Liotta, LA and Martin, GR, 1984, Modulation of the metastatic activity of melanoma cells by laminin and fibronectin. Science, 226, 982–5.
Juliano, RL and Haskill, S, 1993, Signal transduction from the extracellular matrix. J Cell Biol, 120, 577–85.
Terpe, H-J, Tajrobehkar, K, Günthert, U and Altmannsberger, M, 1993, Expression of cell adhesion molecules alpha-2, alpha-5 and alpha-6 integrin, E-cadherin, N-CAM and CD-44 in renal cell carcinomas. An immunohistochemical study. Virchows Archiv A, 422, 219–24.
Favrot, MC, Combaret, V, Goillot, E et al., 1991, Expression of integrin receptors on 45 clinical neuroblastoma specimens. Int J Cancer, 49, 347–55.
Jones, J, Sugiyama, M, Watt, FM and Speight, PM, 1993, Integrin expression in normal, hyperplastic, dysplastic, and malignant oral epithelium. J Pathol, 169, 235–43.
Chan, BMC, Matsuura, N, Takada, Y, Zetter, B and Hemler, ME, 1991, In vitro and in vivo consequences of VLA-2 expression on rhabdomyosarcoma cells. Science, 251, 1600–2.
Nicolson, GL, 1987, Tumor cell instability, diversification, and progression to the metastatic phenotype: from oncogene to oncofetal expression. Cancer Res, 47, 1473–87.
Heino, J and Massagué, J, 1989, Transforming growth factor-β switches the pattern of integrins expressed in MG-63 human osteosarcoma cells and causes a selective loss of cell adhesion to laminin. J Biol Chem, 264, 21806–11.
Arrick, BA, Lopez, AR, Elfman, F et al., 1992, Altered metabolic and adhesive properties and increased tumorigenesis associated with increased expression of transforming growth factor β1. J Cell Biol, 118, 715–26.
Klein, K, Giancotti, FG, Presta, M et al., 1993, Basic fibroblast growth factor modulates integrin expression in microvascular endothelial cells. Mol Biol Cell, 4, 973–82.
Santala, P and Heino, J, 1991, Regulation of integrin-type cell adhesion receptors by cytokines. J Biol Chem, 266, 23505–9.
Defilippi, P, Silengo, L and Tarone, G, 1992, α6β1 integrin (laminin receptor) is down-regulated by tumor necrosis factor a and interleukin-1 β in human endothelial cells. J Biol Chem, 267, 18303–7.
Dedhar, S, 1989, Regulation of expression of the cell adhesion receptors, integrins, by recombinant human interleukin-1β in human osteosarcoma cells: inhibition of cell proliferation and stimulation of alkaline phosphatase activity. J Cell Physiol, 138, 291–9.
Conforti, G, Zanetti, A, Pasquali-Ronchetti, I et al., 1990, Modulation of vitronectin receptor binding by membrane lipid composition. J Biol Chem, 265, 4011–9.
Kirchhofer, D, Grzesiak, J and Pierschbacher, MD, 1991, Calcium as a potential physiological regulator of integrin-mediated cell adhesion. J Biol Chem, 266, 4471–7.
Lampe, BV, Stallmach, A and Riecken, EO, 1993, Altered glycosylation of integrin adhesion molecules in colorectal cancer cells and decreased adhesion to the extracellular matrix. Gut, 34, 829–36.
Tamura, RN, Cooper, HM, Collo, G and Quaranta, V, 1991, Cell type-specific integrin variants with alternative a chain cytoplasmic domain. Proc Natl Acad Sci USA, 88, 10183–7.
Du, X, Plow, EF, Frelinger III, AL et al., 1991, Ligands ‘activate’ integrin αIIbβ3 (platelet GPIIb–IIIa). Cell, 65, 409–16.
Chan, BMC and Hemler, ME, 1993, Multiple functional forms of the integrin VLA-2 can be derived from a single α2 cDNA clone: interconversion of forms induced by an anti-β1 antibody. J Cell Biol, 120, 537–43.
Witkowski, CM, Rabinovitz, I, Nagle, RB, Affinito, KS and Cress, AE, 1993, Characterization of integrin subunits, cellular adhesion and tumorigenicity of four human prostate cell lines. J Cancer Res Clin Oncol, 119, 637–44.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Maemura, M., Akiyama, S.K., Woods, V.L. et al. Expression and ligand binding of α2β1 integrin on breast carcinoma cells. Clin Exp Metast 13, 223–235 (1995). https://doi.org/10.1007/BF00133478
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00133478